Avalanche Biotechnologies(AAVL)

madliu2015-10-17 00:16

$Avalanche Biotechnologies(AAVL)$ 一股有10美金的现金，跌到8块买，是不是价值投资呢？查看全文

Pnmk2015-08-15 01:10

$Avalanche Biotechnologies(AAVL)$ 走下神坛的又一只小生化股查看全文

美股马甲2015-06-24 23:28

$Avalanche Biotechnologies(AAVL)$ 真的出坑？还是诱多继续坑？查看全文

美股马甲2015-06-19 23:00

$Avalanche Biotechnologies(AAVL)$ 被坑了查看全文

美股马甲2015-06-18 09:29

$Avalanche Biotechnologies(AAVL)$ Piper Jaffray's Steven P. Breazzano maintained an Overweight rating and $52 target.查看全文

淡投2015-06-18 08:47

网页链接
did his medical training at Harvard’s Mass Eye & Ear Infirmary (ophthalmology), Stanford Hospital (internal medicine) and UCSF (pathology). it has 13% of portifolio in $Avalanche Biotechnologies(AAVL)$ based upon 3/31 filing查看全文

割资本主义羊毛2015-06-17 03:37

受$Avalanche Biotechnologies(AAVL)$ 影响，gt组全线回调，当然，$Celladon Corporation(CLDN)$ 作为垃圾股已免疫，垃圾股行情又添新成员$Avalanche Biotechnologies(AAVL)$
幸存的GT组员：$SPARK THERAPEUTICS INC(ONCE)$ $BLUEBIRD BIO INC(BLUE)$ $uniQure(QURE)$ $Applied Genetic...查看全文

永远开扇逃生门2015-06-17 02:51

$Avalanche Biotechnologies(AAVL)$ 什么情况查看全文

美股马甲2015-06-17 01:20

$Avalanche Biotechnologies(AAVL)$ 珍爱生命，远离妖股……查看全文

郑坚强2015-06-16 20:51

$Avalanche Biotechnologies(AAVL)$ 果然是mixed data，达到了primary endpoint，但是效果不显著，视敏度只增加了2.2，还出现了一个视网膜增厚的问题，昨天尾盘也是直接被拉到52，最后十几分钟解决战斗投行的评级也是各有不同：jeffies，piper jaffray依然给出了TP 50多，其他一些基本都是20...查看全文

$Avalanche Biotechnologies(AAVL)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-03-03 AccNo: 0001193125-16-490750 Size: 81 KB 网页链接

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-03-03 AccNo: 0001193125-16-490741 Size: 68 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Avalanche Biotechnologies(AAVL)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-02-22 AccNo: 0001193125-16-471645 Size: 12 MB 网页链接

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-02-22 AccNo: 0001193125-16-471644 Size: 12 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Avalanche Biotechnologies(AAVL)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-02-17 AccNo: 0001193125-16-466168 Size: 15 MB 网页链接

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-02-17 AccNo: 0001193125-16-466165 Size: 15 MBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Avalanche Biotechnologies(AAVL)$ 8-K - Current report Filed: 2016-02-16 AccNo: 0001193125-16-465240 Size: 11 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$Avalanche Biotechnologies(AAVL)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0001193805-16-002612 Size: 484 KB 网页链接

$Avalanche Biotechnologies(AAVL)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-11 AccNo: 0001319244-16-000074 Size: 156 KB 网页链接

$Avalanche Biotechnologies(AAVL)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0000315066-16-004837 Size: 9 KB 网页链接